Filing Details

Accession Number:
0001352414-10-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-12 12:00:00
Reporting Period:
2010-03-11
Filing Date:
2010-03-12
Accepted Time:
2010-03-12 16:35:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352414 S James Evans 320 Wakara Way
Salt Lake City UT 84108
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-11 1,680 $8.86 35,971 No 4 M Direct
Common Stock Disposition 2010-03-11 1,680 $23.15 34,291 No 4 S Direct
Common Stock Acquisiton 2010-03-12 6,720 $8.86 41,011 No 4 M Direct
Common Stock Disposition 2010-03-12 6,720 $24.15 34,291 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2010-03-12 6,720 $0.00 6,720 $8.86
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-03-11 1,680 $0.00 1,680 $8.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-04-20 No 4 M Direct
0 2010-04-20 No 4 M Direct
Footnotes
  1. 20% vests annually beginning on the 1st anniversary of the date of the Option Grant.